2015
DOI: 10.1089/aid.2015.0101
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine

Abstract: The development of a highly effective vaccine against the human immunodeficiency virus (HIV) will likely be based on rational vaccine design, since traditional vaccine approaches have failed so far. In recent years, an understanding of what type of immune response is protective against infection and/or disease facilitated vaccine design. T cell-based vaccines against HIV have the goal of limiting both transmission and disease progression by inducing broad and functionally relevant T cell responses. In this con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
14
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 106 publications
1
14
0
Order By: Relevance
“…A DNA vaccine, such as HIVBr18 vaccine, can induce a potent and persistent response of CD4 + T cells with a polyfunctional phenotype and thus can facilitate the cytotoxic activity of these cells. As previously shown in the literature, this type of DNA vaccine may have a protective effect against SIV/HIV infection ( 15 , 18 , 19 , 22 , 84 , 99 106 ). In summary, the adjuvant effect of coadministration of P. acnes with HIVBr18 was evidenced by the potentiation of these responses and the increase in the number of recognized peptides, which generated a broader and more persistent response and reduced the number of administered doses.…”
Section: Discussionsupporting
confidence: 62%
See 1 more Smart Citation
“…A DNA vaccine, such as HIVBr18 vaccine, can induce a potent and persistent response of CD4 + T cells with a polyfunctional phenotype and thus can facilitate the cytotoxic activity of these cells. As previously shown in the literature, this type of DNA vaccine may have a protective effect against SIV/HIV infection ( 15 , 18 , 19 , 22 , 84 , 99 106 ). In summary, the adjuvant effect of coadministration of P. acnes with HIVBr18 was evidenced by the potentiation of these responses and the increase in the number of recognized peptides, which generated a broader and more persistent response and reduced the number of administered doses.…”
Section: Discussionsupporting
confidence: 62%
“…HIV-specific and polyfunctional CD4 + T lymphocytes were shown to be more frequent in long-term non-progressor patients than in patients who rapidly progressed to AIDS ( 99 , 100 ). Therefore, the polyfunctional responses of HIV-specific CD4 + T cells might be potentiated by the presence of P. acnes and might contribute to the control of disease progression ( 101 106 ). We also observed higher levels of Th1 cytokines when P. acnes was administered in the first dose than when it was administered in both doses.…”
Section: Discussionmentioning
confidence: 99%
“…However, multi-epitope based recombinant vaccines offer numerous advantages compared to the complete protein including cost-effective production, multi-valency, and stability under different conditions. Moreover, the efficacy of epitope vaccines can be further improved by combining CD4 + T helper and promiscuous epitopes, employing epitope enhancement techniques (such as immune-informatics or computational immunology), and adopting toll-like receptor (TLR) ligands as an adjuvant (Nezafat et al, 2014;Rosa et al, 2015). Consequently, in order to enable rational multi-epitope vaccine and diagnostic antigen design, it is imperative to delineate the BCEs on the target antigens.…”
Section: Discussionmentioning
confidence: 99%
“…Epitope-focused vaccine design is an appealing method, by which minimized antigen epitopes are designated to develop into a TB vaccine resulting in retaining one or more key epitopes while eliminating other potentially distracting or unnecessary features (20,34,35). Until now, much evidence has proved that epitope-focused vaccine could effectively protect against cancer and infectious diseases (36)(37)(38)(39)(40).…”
Section: Discussionmentioning
confidence: 99%